Share ConsumerLab.com's information with family and friends — or just send to yourself. Simply provide an email address below.
You must provide a valid email address.
Your email address*:
Your name*: Send me a copy
Email Address where it's going*:
*Addresses and name will only be used for sending this message.
Additional message (optional):
Your message has been sent. Thanks for sharing!
THIS CONTENT IS COPYRIGHT PROTECTED
As a ConsumerLab.com member, you may print a copy of this report for your personal use. You can access a special print version by clicking the "Print" icon in the upper right corner of this report or by clicking here. You can then use your web browser's print functions to print the whole report or just selected pages.
You may also email or post a link to this report using the web address above. Non-members using the link will see a free summary and can join to view the full report. Other means of copying or distributing this report, in part or full, are not permitted.
If you are sight-impaired and your computer is having trouble converting the text in this report to speech, contact us for assistance at Membership@ConsumerLab.com or by phone at 888-676-9929, ext. 2#.
Red Yeast Rice Supplements Review
Initial Posting: 8/16/18 Last update: 10/26/2018
Sections: Jump to a section by clicking on its name.
What is it? Red yeast rice (i.e., rice on which a particular yeast has grown) naturally contains cholesterol-lowering lovastatin compounds (which are red in color) (see What It Is).
Does it work? Red yeast rice can be very effective in lowering elevated levels of cholesterol, as shown in several clinical trials (see What It Does). However, not all red yeast rice supplements contain the amounts of lovastatins needed to lower cholesterol, and products normally do not list the amount of lovastatins they contain on their labels.
What did CL find? The amount of lovastatins in the tested supplements ranged 1,500% -- from just 0.43 mg to 6.44 mg per 2-pill serving. When used according to their suggested serving sizes, only two of nine products provided amounts known to lower cholesterol in clinical trials (see What CL Found). One of these two was half the price of the other, making it our Top Pick. ConsumerLab also found that lovastatin levels had fallen by 37 to 81% since 2014 in products it previously tested. This could result in decreasing efficacy.
Should you use it? Based on the varying amounts of lovastatins in products and decreases in these amounts over time, it may be preferable to use a prescription statin drug to ensure a more consistent dose (prescription lovastatin is also available at a lower cost than lovastatin from red yeast rice) (see ConsumerTips). However, red yeast rice may be effective for some people who don't respond to statin drugs and certain side effects may be diminished.
How to take it? It is best to take red yeast rice in two divided doses each day, with one dose before bedtime, as this may improve efficacy. Typically, 1,200 to 2,400 mg of red yeast rice is taken daily (two to four 600 mg pills). (Rarely, taking red yeast rice at night may cause insomnia in some people).
Cautions: Red yeast rice can cause digestive upset and other mild symptoms, and may also, like other statins, cause muscle breakdown. It can also negatively interfere with certain medications. Don't eat grapefruit or use St. John's wort when taking red yeast rice or other statins. See Concerns and Cautions for more information.
Red Yeast Rice Supplements Reviewed by ConsumerLab
What It Is:
Red yeast rice is a substance made by fermenting rice with a species of yeast called Monascus purpureus. The fermented rice has been used as a food and a traditional medicine in China for over 1,000 years (since 800 AD). Red yeast rice naturally contains a variety of compounds known as monacolins (or mevinic acids). Some of these monacolins are known to inhibit cholesterol production by inhibiting the enzyme HMG-CoA reductase.
Among the monacolins in red yeast rice is monacolin-K, also known as lovastatin. Lovastatin is the key ingredient in the prescription drug Mevacor®, one of the "statin" drugs used to lower cholesterol levels in people with high cholesterol. Closely related to monacolin-K is its hydroxy acid form (known as monacolin KA), which is the activated form of lovastatin after it passes through the liver. Lovastatin and its hydroxy acid form are typically the predominant monacolins in red yeast rice. (In this Review, the term "total lovastatins" refers to the sum of these two compounds in any red yeast rice product.)
What It Does:
Several well-designed human studies have found that red yeast rice taken daily for two to three months lowers total cholesterol, low-density lipoprotein (LDL) cholesterol, and triglycerides in people with elevated cholesterol. In one study, total cholesterol fell by an average of 18%, LDL by 23% and triglycerides by 15% (Heber, Am J Clin Nutr 1999). Reductions in cholesterol of this magnitude can occur on top of reductions from improving one's diet. This was shown in a study in which red yeast rice (containing 10 mg of lovastatin) along with 30 mg of CoQ10 was given daily in conjunction with a change to a Mediterranean diet which, in itself, was able to reduce cholesterol levels but not as much as with red yeast rice. The red yeast rice also helped further reduce blood pressure and blood glucose levels (Mazza Biomed Pharmacother 2018). In fact, when combined with lifestyle changes recommended by the American Heart Association and fish oil use, a more dramatic decrease in LDL (a 42% decline) has been reported (Becker, Mayo Clinic Proc 2008). In these studies, levels of high-density lipoprotein (HDL, "good cholesterol") did not significantly change. (Note: CoQ10 can modestly lower cholesterol levels when taken alone and is sometimes added to red yeast rice supplements, possibly because statins may decrease the body's own levels of CoQ10.)
Although these studies were too short to fully assess effects on mortality, a study in China of several years duration among people with a previous heart attack showed a significant decrease in recurrent heart attacks, heart attack-related deaths, and the need for angioplasty or heart surgery (Lu, Am J Cardiol 2008). In this study, a 20% decrease in LDL cholesterol and a 4% increase in HDL cholesterol were also observed.
The total amount of lovastatin in clinically tested red yeast rice is typically less than half the amount used in prescription lovastatin products. For example, in recent clinical studies, the daily amount of lovastatin in the red yeast rice preparations has ranged from 5 mg to 18 mg. The standard dose of lovastatin prescribed to achieve LDL reductions of 30% to 40% is typically 20 mg to 40 mg. A likely explanation for this difference is that red yeast rice contains a variety of compounds, including other monacolins that may contribute to cholesterol lowering. For more information about dosage, see What to Consider When Using and Buying.
Because of these other compounds, red yeast rice may be effective in people who do not respond to prescription statins and side-effects seen in patients treated only with lovastatin may potentially be diminished because of the lower amount of lovastatin in typical dosages of red yeast rice. In fact, among a group of people who experienced muscle pain with a statin drug, only 7% of reported muscle pain when switched to red yeast rice (Becker, Ann Int Med 2009). A small, 4-week study which compared red yeast rice (300 mg, four times daily, providing a total of 10 mg of lovastatin) to simvastatin (Zocor) (20 mg daily) found a similar cholesterol-lowering effect of each treatment but slightly more muscle fatigue and reduced physical activity with simvastatin than red yeast rice (Xue, BMC Cardio Disorders 2017). Even among people using a marketed red yeast rice product of their own choosing, 92% who were previously intolerant to statin drugs were able to tolerate red yeast rice and achieved an average LDL reduction of 21% (Venero, Am J Cardiol 2010). See Concerns and Cautions for potential side-effects of red yeast rice.
Although based on only a single case report, red yeast rice may also further lower cholesterol levels in people taking the non-statin cholesterol-lowering medications evolocumab and ezetimibe, as seen in the case of a 47-year-old woman with statin intolerance and familial hypercholesterolemia. The prescription medications lowered her LDL and total cholesterol levels from 363 mg/dL and 445 mg/dL, respectively, to 115 mg/dL and 185 mg/dL, but adding a daily dose of red yeast rice (providing 3 mg of lovastatin — similar to several products in this Review) and berberine (500 mg — for which there is preliminary evidence of a cholesterol-lowering effect) further lowered her levels to 68 mg/dL and 143 mg/dL, respectively (Parra-Virto, Clin Investig Arterioscler 2018).
In the late 1990s the marketing of a prominent red yeast rice product (Cholestin®) was challenged because its label listed the amounts of lovastatin contained in each dose and made specific claims about the product's ability to lower cholesterol. The FDA determined that Cholestin®, by containing lovastatin, was an unapproved drug and ordered it removed from sale. (A reformulated version of Cholestin®, containing no red yeast rice, is currently sold in the US). However, other red yeast rice dietary supplements continue to be sold in the US. Their labels state only the amount of red yeast rice, not the amount of total or individual monacolins. In August of 2007, the FDA sent warning letters to several companies promoting the cholesterol-lowering effect of their red yeast rice supplements. The FDA classified these products as unapproved drugs and issued a warning to consumers to avoid these products. It appears that products that did not claim to lower cholesterol or prevent disease did not receive warnings. However, any supplement containing more than trace amounts of lovastatin may technically be in violation of FDA policy.
Quality Concerns and What CL Tested for:
There are no standards for amounts of lovastatin (monacolins K and KA) in red yeast rice dietary supplements and, due to the regulatory issues noted above, these levels are generally not listed on supplements. This makes it very difficult to anticipate and gauge the safety and efficacy of products. A study of nine red yeast rice supplements published in 2001 (Heber, J Alt Comp Med 2001) also found great variation in types and amounts of monacolins across products. That report emphasized that clinical results with one product should, therefore, not be generalized to other products. Reasons for variations may include differences in strains of yeast, culture conditions and media, procedures for extracting and concentrating the compounds, drying, and other manufacturing processes. Tests by ConsumerLab.com in 2008 of ten red yeast rice products showed a 100-fold range in total lovastatins. (These results were published by ConsumerLab.com in 2008 and were subsequently published in a scientific paper in Archives of Internal Medicine in 2010 (Gordon, Arch Int Med 2010). Most recently, tests of 28 brands of red yeast rice purchased from major retail chains in the U.S. showed that monacolin K was not detectable in two brands and ranged more than 60-fold among the remaining brands (from 0.09 to 5.48 mg per 1,200 mg of red yeast rice (Cohen, Eur J Prev Cardiol 2017). [Note: Unlike ConsumerLab's Review, this study did not measure amounts of monacolin KA, which also has cholesterol-lowering activity, nor amounts of the toxin citrinin (described below), and did not identify names of the tested brands.]
Another concern with red yeast rice is that it may inherently contain amounts of citrinin — a potential toxin that can be produced by yeast or fungi grown on corn, rice and other cereal grains. In animals, citrinin has been shown to damage kidneys. Similar effects are suspected in humans but have not been proven. Citrinin is typically not found in high levels in human food because it is eliminated during processing and baking. (See Citrinin Contamination for more information.)
In addition to these concerns, a study by researchers at Oregon State University showed that the FDA has no routine sampling or analysis program for red yeast rice products and, as with other types of dietary supplements, the FDA does not track products on the market or know which are made under Good Manufacturing Practices (Childress, J Clin Lipidol 2013).
ConsumerLab.com, as part of its mission to independently evaluate products that affect health, wellness, and nutrition, purchased red yeast rice dietary supplements sold in the U.S. and tested them for their levels of lovastatins and citrinin. Any supplement in the form of a regular tablet underwent disintegration testing to see if it would properly break apart.